Diversified Healthcare Trust
DHC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $1,495,427 | $1,410,308 | $1,283,566 | $1,383,212 |
| % Growth | 6% | 9.9% | -7.2% | – |
| Cost of Goods Sold | $1,239,052 | $1,185,004 | $1,109,070 | $1,091,812 |
| Gross Profit | $256,375 | $225,304 | $174,496 | $291,400 |
| % Margin | 17.1% | 16% | 13.6% | 21.1% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $26,518 | $26,131 | $26,435 | $34,087 |
| SG&A Expenses | $26,518 | $26,131 | $26,435 | $34,087 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $239,280 | $271,131 |
| Operating Expenses | $26,518 | $26,131 | $265,715 | $305,218 |
| Operating Income | $229,857 | $199,173 | -$91,219 | -$13,818 |
| % Margin | 15.4% | 14.1% | -7.1% | -1% |
| Other Income/Exp. Net | -$599,645 | -$492,300 | $76,155 | $195,174 |
| Pre-Tax Income | -$369,788 | -$293,127 | -$15,064 | $181,356 |
| Tax Expense | $467 | $445 | $710 | $1,430 |
| Net Income | -$370,255 | -$293,572 | -$15,774 | $174,515 |
| % Margin | -24.8% | -20.8% | -1.2% | 12.6% |
| EPS | -1.55 | -1.23 | -0.066 | 0.73 |
| % Growth | -26% | -1,758% | -109.1% | – |
| EPS Diluted | -1.55 | -1.23 | -0.066 | 0.73 |
| Weighted Avg Shares Out | 239,535 | 238,836 | 238,318 | 237,967 |
| Weighted Avg Shares Out Dil | 239,535 | 238,836 | 238,314 | 237,967 |
| Supplemental Information | – | – | – | – |
| Interest Income | $8,950 | $15,536 | $15,929 | $20,635 |
| Interest Expense | $235,239 | $191,775 | $209,383 | $255,759 |
| Depreciation & Amortization | $285,063 | $283,841 | $239,525 | $271,131 |
| EBITDA | $229,963 | $198,931 | $427,789 | $708,246 |
| % Margin | 15.4% | 14.1% | 33.3% | 51.2% |